Shopping Cart
- Remove All
Your shopping cart is currently empty
Zanubrutinib-d5 (BGB-3111-d5), a deuterium-labeled Zanubrutinib, is an orally available Bruton's tyrosine kinase inhibitor for the study of B-cell malignancies.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $514 | 7-10 days | |
| 5 mg | $1,540 | 7-10 days | |
| 10 mg | $2,570 | 7-10 days | |
| 25 mg | $4,750 | 7-10 days |
| Description | Zanubrutinib-d5 (BGB-3111-d5), a deuterium-labeled Zanubrutinib, is an orally available Bruton's tyrosine kinase inhibitor for the study of B-cell malignancies. |
| Synonyms | BGB3111-d5, BGB-3111-d5 |
| Molecular Weight | 476.58 |
| Formula | C27H29N5O3 |
| Smiles | O=C(N)C1=C2NCC[C@@H](C3CCN(C(C=C)=O)CC3)N2N=C1C4=CC=C(OC5=C([2H])C([2H])=C([2H])C([2H])=C5[2H])C=C4 |
| Color | White |
| Appearance | Solid |
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20.00 mg/mL (41.97 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.